PTX 2.44% 4.2¢ prescient therapeutics limited

Ann: PTX-100 trial advances following successful Phase 1b, page-16

  1. 1,348 Posts.
    lightbulb Created with Sketch. 319
    This will be interesting.... 1 patient showing remarkable stability in disease, with a second showing partial responses, thats out of 10 patients, the market might need to see more before we get above 30C... hopefully the big boys like it and take up longer term positions, and it's not just traded on a shorter term basis... best of luck everyone!
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.